The Effect of Wheat Germ on Gastrointestinal Discomfort, Blood Cholesterol and Postprandial Glycaemic Response

NCT ID: NCT02405507

Last Updated: 2019-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Wheat germ is a by-product of the wheat-milling industry with high nutritional value and therefore could be used as a raw source for the preparation of food products such as bread, cookies, muffins, etc.

The aim of this study is to assess the effects of ingesting wheat breads supplemented with wheat germ on gastrointestinal discomfort, blood cholesterol and postprandial glycaemic response in healthy human volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a crossover, double blinded, placebo controlled randomized trial. The study will compare the effect of consumption of wheat breads with or without wheat germ on healthy individuals, during 2 intake periods of 4 weeks each and 5 weeks washout before crossover.

The study will focus on the effects of wheat breads supplemented with wheat germ on gastrointestinal discomfort, blood cholesterol and postprandial glycaemic response in healthy human volunteers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

wheat bread with wheat germ

wheat bread with wheat germ supplementation

Group Type EXPERIMENTAL

wheat bread with wheat germ

Intervention Type DIETARY_SUPPLEMENT

wheat bread without wheat germ

wheat bread without wheat germ supplementation

Group Type PLACEBO_COMPARATOR

wheat bread without wheat germ

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

wheat bread with wheat germ

Intervention Type DIETARY_SUPPLEMENT

wheat bread without wheat germ

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult men or women
* Age 18 - 60 years
* Healthy volunteers free of chronic diseases with relevant effect on the gastrointestinal system or on visceral motility
* Without a diagnosis of any digestive disease including functional bowel disorders such as IBS
* Non-diabetic, no gastric bypass surgery
* Have a fasting plasma glucose (finger-stick) \<100 mg/dl (\<5.5 mmol/L)
* Non-smoker
* Willing and able to provide written informed consent

Exclusion Criteria

* Subject under prescription for medication for digestive symptoms such as anti-spasmodic, laxatives and anti-diarrheic drugs or other digestive auxiliaries
* Relevant history, presence of any medical disorder or intake of medication / dietary supplements, potentially interfering with this trial at screening
* Subjects with stool frequency of ≤ 1 stool every 7 days
* Subjects not willing to avoid pre- and probiotics for the duration of the study
* Intake of antibiotics in the last 4 weeks and laxatives in the last 2 weeks
* Current use of medication for lowering blood cholesterol or glucose
* Change of dietary habits within the 4 weeks prior to screening (for instance start of a diet high in fibres)
* Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject
* Subjects with history of drug, alcohol or other substances abuse, or other factors limiting their ability to co-operate during the study
* Participants anticipating a change in their lifestyle or physical activity levels since this may also influence the results
* Known food intolerance or allergy
* Subject involved in any clinical or food study within the preceding month
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Center for Health Technology and Services Research

OTHER

Sponsor Role collaborator

Project VALORINTEGRADOR financed by COMPETE (FCOMP-01-0202-FEDER-038861)

UNKNOWN

Sponsor Role collaborator

Universidade do Porto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Conceição Calhau, PhD

Role: PRINCIPAL_INVESTIGATOR

CINTESIS, Faculty of Medicine of the University of Porto

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PtCRIN

Lisbon, , Portugal

Site Status

CINTESIS - Faculty of Medicine of the University of Porto

Porto, , Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

References

Explore related publications, articles, or registry entries linked to this study.

Moreira-Rosario A, Marques C, Pinheiro H, Norberto S, Sintra D, Teixeira JA, Calhau C, Azevedo LF. Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial. Eur J Nutr. 2020 Aug;59(5):1951-1961. doi: 10.1007/s00394-019-02045-x. Epub 2019 Jul 19.

Reference Type RESULT
PMID: 31325040 (View on PubMed)

Moreira-Rosario A, Pinheiro H, Marques C, Teixeira JA, Calhau C, Azevedo LF. Does intake of bread supplemented with wheat germ have a preventive role on cardiovascular disease risk markers in healthy volunteers? A randomised, controlled, crossover trial. BMJ Open. 2019 Jan 17;9(1):e023662. doi: 10.1136/bmjopen-2018-023662.

Reference Type RESULT
PMID: 30659039 (View on PubMed)

Moreira-Rosario A, Pinheiro H, Calhau C, Azevedo LF. Can wheat germ have a beneficial effect on human health? A study protocol for a randomised crossover controlled trial to evaluate its health effects. BMJ Open. 2016 Nov 10;6(11):e013098. doi: 10.1136/bmjopen-2016-013098.

Reference Type DERIVED
PMID: 28157671 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VI001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Barley Bread and Metabolic Disease
NCT02867215 COMPLETED NA
Grain Fibre and Gut Health
NCT03550365 COMPLETED NA
Effect of Peas in Soup on Blood Glucose Control
NCT03306862 ACTIVE_NOT_RECRUITING NA